(Q35025817)

5 August 2017

title

The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man (English)

1 reference

5 August 2017

Ur E

1

1 reference

5 August 2017

Wright DM

series ordinal

2

1 reference

5 August 2017

Bouloux PM

series ordinal

3

1 reference

5 August 2017

Grossman A

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

British Journal of Pharmacology

5 August 2017

published in

1 reference

5 August 2017

volume

120

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

781-784

1 reference

Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

Effects of the kappa-opioid agonist U50,488 on parturition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

Mechanism of diuretic action of spiradoline (U-62066E)-a kappa opioid receptor agonist in the human

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Measurement of circulating corticotrophin-releasing factor in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Kappa agonists and vasopressin secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

κ-opiates and urination: Pharmacological evidence for an endogenous role of the κ-opiate receptor in fluid and electrolyte balance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective kappa-opioid receptor agonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

[3H]U-69593 a highly selective ligand for the opioid kappa receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Anatomy of CNS opioid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Anterior pituitary hormone responses to a kappa-opioid agonist in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Effect of morphine on the basal and the dopamine-induced release of LHRH from mediobasal hypothalamic fragments in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Displacement of 3H-EKC binding by opioids in rat kidney: a correlate to diuretic activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Opiate receptor binding in the pituitary gland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700971

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0700971

1 reference

5 August 2017

1 reference

5 August 2017

1 reference